国際学会

Sakurai K, Isahaya K, Imai T, Tsuchihashi Y, Yamano Y.
Step are a Candidate Digital Biomarker for Fatigue and Mood in Multiple Sclerasis.
15th Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis(PACTRIMS), Nov 23 2023, Ritz-Carlton, Perth Austlaria. 〈Poster Presentation〉

Shiraishi M, Mikami K, Kamo H, Tsunemi T, Okuma Y, Fujimoto K, Yokota Y, Nogawa S, Osada T, Seki M, Nagayama H, Hatano T, Nakajima H, Suzuki K, Yamamoto T, Yamano Y, Hattori N, Iijima M.
Effect Recognition of Vertical Posture on Forward Bending Posture in Patients with Parkinson’s Disease: A Multicenter Observational Study.
International Congress of Parkinson’s Disease and Movement Disorder 2023, Aug 28 2023, Bella Center Copenhagen 〈Poster Presentation〉

Mitsuhashi S, Tachikawa K, Imai K, Isahaya K, Shimizu T, Yamano Y. Applications of long-read sequencing in clinical Neurology.
European Society of Human Genetics conference (ESHG 2023), Jun 12 2023, Hybrid Conference (Glasgow+Web)

Kurokawa M, Sato T, Sato M, Nagai K, Fukasawa M, Nagashima Y, Uchida T, Tsutiya A, Omoteyama K, Arito M, Takakuwa Y, Ooka S, Suematsu N, Kawahata K, Yamano Y, Kato T. Serum peptides as candidate biomarkers for relapsing polychondritis.
EULAR 2023 Congress, 31 May-3 Jun 2023, MiCo (Milano Convention Centre, V.le Eginardo, 7, 20145 Milan, Italy)

Isahaya K, Shiraishi M, Shibata S, Kimura A, Shimohata T, Yamamo Y. a case of progressive dementia with involuntary movements in 69 years-old man.
The 22nd Takamatsu International Symposium for PD&MD in Tokyo, Mar 24 2023, 〔東京都国際交流館 国際交流会議場〕

Yamauchi J, Sato T, Yagishita N, Araya N, Nakagawa M, Matsuura E, Tsuboi Y, Tamaki K, Sakima H, Ishihara S, Araujo A, Jacobson S, Grassi MFR, Galvão-Castro B, Bland M, Taylor GP, Martin F, Yamano Y.
A randomized controlled trial on corticosteroid therapy for HTLV-1-associated myelopathy/tropical spastic paraparesis in Japan (HAMLET-P trial).
20th International Conference on Human Retrovirology: HTLV and Related Viruses(HTLV22), 8 – 11 May 2022, Melbourne, Australia.

Sato T, Yagishita N, Araya N, Yamauchi J, Takahashi K, Kunitomo Y, Hasegawa Y, Higashikuse Y, Miyachi K, Yamano Y. Evaluation of quantification method of HTLV-1 proviral load in white blood cells using whole blood.
20th International Conference on Human Retrovirology: HTLV and Related Viruses(HTLV22), 8 – 11 May 2022, Melbourne, Australia.

Matsumoto H, Shiraishi M, Mizukami H, Hino S, Kaburagi M, Ono J, Nakagawa R, WarashinaK, Mizuno S, Tochimoto S, Yamano Y. Quantification of neck and trunk tilt during standing in Parkinson’s disease.
MDS Virtual Congress 2021, 13 Sep 2021, virtual meetring. <ポスター>

Yamano Y.
Pathogenesis and Genomic Changes during leukemic transformation in patients with HTLV-1-associated neuroinflammatory disease.
19th International Symposium on Epstein-Barr Virus and associated diseases, 29 July 2021, Face to face meeting & Live streaming.

Matsumoto H, Shiraishi M, Tochimoto S, Tanaka K, Uchino K, Hasegawa Y, Yamano Y.
Predictive factors of serious falls in Parkinson’s disease.
MDS Virtual Congress 2020, 12 September 2020, virtual meeting. <ポスター>

Shiraishi M, Maki F, Morosawa Y, Takumi I, Isahaya K, Sasaki N, Hasegawa Y, Yamano Y.
Indication and long-term outcome of device-aided therapies in advanced Parkinson’s disease.
MDS Virtual Congress 2020, 12 September 2020, virtual meeting. <ポスター>

Nakajima T, Yoshifuji H, Yamano Y, Handa H, Ohmura K, Mimori T, Terao C.
Detailed Profile of co-occurrence of Relapsing Polychondoritis and Autoimmune Thyroid Disease.
EULAR 2020 E-congress, 4 July 2020, E-Congress.

Yamano Y.
Anti-CCR4 monoclonal antibody therapy in HTLV-1-associated neuroinflammatory disease.
2019 NIH-Japan-JSPS Symposium, 28-29 October 2019, Bethesda, MD, USA.

Yamano Y.
Recent Progress of therapeutic strategy for a rare disease HTLV-1-associated myelopathy.
The 7th McGill-Kyoto Training Course & Symposium Genomics and Data: The Future for Health Care Health Innovation through genomics, 31 October 2019, Montreal, Canada.

Yamauchi J, Yamano Y, Matsuoka M, Ichimaru N, Nishikido M, Shibagaki Y, Sugitani A, Nakamura N, Mieno M, Yuzawa K.
High risk of HAM/TSP after HTLV-1 infection via kidney transplantation: A nationwide survey in Japan.
The 19th International Conference on Human Retrovirology: HTLV and Related Viruses, 24-26 April 2019, Lima, Peru.

Sato T, Yagishita N, Araya N, Yamauchi J, Inoue E, Matsumoto N, Hasegawa Y, Yamano Y.
Progress report on a long-term study of anti-CCR4 antibody (mogamulizumab) in patients with HAM/TSP.
The 19th International Conference on Human Retrovirology: HTLV and Related Viruses, 24-26 April 2019, Lima, Peru.

Yamano Y.
Treatment of HAM/TSP.
The 19th International Conference on Human Retrovirology: HTLV and Related Viruses, 24-26 April 2019, Lima, Peru.

Yamano Y.
Anti-C-C chemokine receptor 4 monoclonal antibody therapy in human T-lymphotropic virus type 1-associated myelopathy (HAM/TSP).
11th Pan-Asian Committee on Treatment and Research in Multiple Sclerosis (PACTRIMS CONGRESS 2018), 1-3 November 2018, Sydney, Australia.

Yamano Y.
Current situation of patient centered medicines development in Japan.
The 19th International Conference on Pharmaceutical Medicine (ICPM2018), 27-29 September 2018(27), Tokyo, Japan.

Yamano Y.
Recent progress of therapeutic strategy for HTLV-1-associated myelopathy (HAM/TSP).
The 14th International Congress of Neuroimmunology (ISNI 2018), 27-31st August, 2018, Brisbane Australia.

Yamano Y.
Treatment of HAM/TSP .
IRVA Tokyo Conference 2018 & International Symposium , 12 July 2018, Tokyo, Japan.

Yamano Y, Sato T, A. Coler-Reilly, Yanagisawa N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y.
Phase 1/2a study of Mogamulizumab, an anti-CCR4 monoclonal antibody, in patients with HTLV-1-associated myelopathy (HAM/TSP).
XXIII World Congress of Neurology, 20 September 2017, Kyoto, Japan.

Yamano Y.
Establishment of a platform to accelerate rare disease data registries in Japan.
The Office of Rare Disease Research (ORDR) of the National Center for Advancing, 28 June 2017, Bethesda, Maryland, U.S.A.

Kawano N, Yamano Y, Kawano S, Kawamata T, Yoshida S, Kuriyama T, Uchimaru K, Marutsuka K, Minato S, Yamashita K, Ochiai H, Shimoda K, Ishikawa F, Kikuchi I.
The Development of Human T-cell Leukemia Virus Type 1 (HTLV-1)-Associated Myelopathy (HAM)-Mimicking Myelitis Following Allogeneic Hematopoietic Stem Cell Transplantation for Acute Type Adult T-cell Leukemia-lymphoma (ATL).
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Tada M, Yamano Y, Sato T, Sasaki M, Sakate R, Hinomura A, Hirata M, Tanaka H, Kojima H, Kohara A, Matsuyama A.
Investigation of Human Leukocyte Antigen on Human T-Lymphotropic Virus Type-1 Associated Myelopathy (HAM) by the Rare Disease Bank.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Matsuzaki T, Saito M, Yamano Y, Nagai M, Takashima H, Izumihara T, Yoshitama T, Kubota R.
Effect of Biologic Agents on HAM/TSP with Rheumatoid Arthritis.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Tamaki K, Sato T, Coler-Reilly A, Inoue E, Tsugawa J, Yamano Y, Tsuboi Y.
Biomarkers for Predicting Treatment Response in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Yamagishi M, Nakano K, Fujikawa D, Kobayashi S, Araya N, Sato T, Yagishita N, Iwanaga M, Utsunomiya A, Tanaka Y, Yamano Y, Watanabe T, Uchimaru K.
Comparative Transcriptome Analysis of HTLV-1-infected Cells and ATL Cells.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Sawada L, Nagano Y, Hasegawa A, Ito S, Sato T, Yamano Y, Tanaka Y, Masuda T, Kannagi M.
IL-10-mediated Signals as a Switch to Proliferation in HTLV-1-infected T Cells.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Yuzawa K, Matsuoka M, Yamano Y, Ichimaru N, Nishikido M, Shibagaki Y, Sugitani A, Nakamura N, Mieno M, Yamauchi J.
High Risk with Human T-cell Leukemia Virus Type 1 for HTLV-1 Associated Myelopathy after Living Kidney Transplantation in Japan.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Higashikuse Y, Nagai G, Araya N, Yagishita N, Sato T, Yamano Y. Development of a New Assay for Quantification of HTLV-1 Proviral DNA. 18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Suzuki H, Sato K, Kikuchi T, Kimura M, Arifuku H, Komita M, Shimada K, Seki K, Tachibana M, Yagishita N, Coler-Reilly A, Sato T, Araya N, Ishikawa M, Koike M, Saito Y, Takata A, Yamano Y.
Patient Satisfaction Survey for HAM-net Registrants.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Inoue E, Coler-Reilly A, Araya N, Yagishita N, Sato T, Takata A, Yamano Y.
Progression Patterns of Osame’s Motor Disability Score for HAM/TSP Patients.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Yamakawa N, Amano S, Kawakami H, Yamashita H, Yagishita N, Araya N, Sato T, Takata A, Matsuo T, Yamano Y.
A New Index Describing Urinary Dysfunction in Patients with Human T-lymphotropic Virus Type 1-associated Myelopathy.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Coler-Reilly A, Sato T, MatsuzakiT, Nakagawa M, Niino M, Nagai M, Nakamura T, Takenouchi N, Araya N, Yagishita N, Yamano Y.
Daily Prednisolone Slows the Progression of HAM/TSP.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Sato T, Inoue E, Yagishita N, Araya N, Takata A, Yamano Y.
Effectiveness of Low-Dose Oral Prednisolone to Treat and Slow Progression of HAM/TSP: A Nationwide Prospective Cohort Study.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Araya N, Sato T, Yagishita N, Coler-Reilly A, Uchimaru K, Yamano Y.
Prevalence, Incidence, and Evidence of High ATL Risk among HAM/TSP Patients.
18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Yamano Y. The New Phase of HAM/TSP Research. 18th International Conference on Human Retrovirology: HTLV and Related Viruses, 7-10 March 2017, Tokyo, Japan.

Yamano Y.
Viruses in neuroimmunological disorders.
13th International Congress of Neuroimmunology(ISNI 2016), 26-29 September 2016, Jerusalem, Israel.

Ishihara M, Araya N, Sato T, Saichi N, Fujii R, Yamano Y, Ueda K.
Membrane Proteome Profiling to Discover Therapeutic Targets for HTLV-1 Associated Myelopathy:
14th Human Proteome Organization 27-30 Septeber 2015, Vancouver, BC, Canada.

Yamano Y. How does HTLV-1 cause CNS disease? – The importance of cross-talk between infected T-cells and astrocytes. The Inaugural Asia-Pacific School of Neuroimmunology Meeting〔APSNI〕(第一回アジア太平洋神経免疫学国際シンポジウム), 30 August 2015, Tokyo, Japan.

Yamano Y, Yamauchi J, Coler-Reilly A, Sato T, Araya N, Yagishita N, Kunitomo Y, Takahashi K, Tanaka Y, Akiyama H, Hasegawa Y, Utsunomiya A. Humanized anti-CCR4 antibody KW0761 targets HTLV-1-infected CD4+CCR4+ and CD8+CCR4+ T-cells to treat HAM/TSP.
17th International Conference on Human Retrovirology: HTLV and Related Viruses, 18-21 June 2015, Trois-Ilets, Martinique, French West Indies (FWI).

Araya N, Sato T, Tomaru U, Coler-Reilly A, Yagishita N, Yamauchi J, Hasegawa A, Kannagi M, Akiyama H,Hasegawa Y, Takahashi K, Kunitomo Y, Tanaka Y, Utsunomiya A, Jacobson S, Yamano Y. HTLV-1 Tax induces Th1 master regulator T-bet and thus IFN-γ in CD4+CCR4+ T-cells of virus-associated myelopathy patients. 17th International Conference on Human Retrovirology: HTLV and Related Viruses, 18-21 June 2015, Trois-Ilets, Martinique, French West Indies (FWI).

Coler-Reilly A, Yagishita N, Sato T, Araya N, Ishikawa M, Koike M, Saito Y, Suzuki H, Yamano Y, Takata A. HAM-net national patient registration system reveals details of how Japanese patients with HTLV-1-associated myelopathy/tropical spastic paraparesis progress over time. 17th International Conference on Human Retrovirology: HTLV and Related Viruses, 18-21 June 2015, Trois-Ilets, Martinique, French West Indies (FWI).

Kimura M, Yamauchi J, Taisho H, Sato T, Yagishita N, Araya N, Sato K, Kikuchi T, Hasegawa Y, Chikaraishi T,  Shibagaki Y, Yamano Y. Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors. 17th International Conference on Human Retrovirology: HTLV and Related Viruses, 18-21 June 2015, Trois-Ilets, Martinique, French West Indies (FWI).

Sato K, Kikuchi T, Kimura M, Komita M,Shimada K, Seki K, Tachibana M, Yagishita N, Coler-Reilly A, Sato T, Arayta N, Ishikawa M, Koike M, Saito Y, Suzuki H, Takata A, Yamano Y. Patient Satisfaction Survey for HAM-net Registrants. 17th International Conference on Human Retrovirology: HTLV and Related Viruses, 18-21 June 2015, Trois-Ilets, Martinique, French West Indies (FWI).

Kikuchi T, Sawabe A, Negishi Y, Noda A, Hirai Y, Inoue E, Kimura M, Sato K, Araya N, Yagishita N, Sato T, Yamano Y. Evaluation of clinical outcome measures for HAM/TSP. 17th International Conference on Human Retrovirology: HTLV and Related Viruses, 18-21 June 2015, Trois-Ilets, Martinique, French West Indies (FWI).

Ishihara M, Araya N, Sato T, Saichi N, Fujii R, Yamano Y, Ueda K.
A three-factor plasma diagnostic model of human T -cell leukemia virus-1 associated myelopathy: 17th International Conference on Human Retrovirology: HTLV and Related Viruses, 18-21 June 2015, Trois-Ilets, Martinique, French West Indies (FWI).

Yamano Y.
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM/TSP.
40Years of Neuroimmunology, 19-20 April 2015, Bethesda, Maryland, USA.

Yamauchi J, Sato T, Yagishita N, Araya N, Chikaraishi T, Shibagaki Y, Yamano Y.
HTLV-1-Associated Myelopathy in Preoperatively HTLV-1 Negative Recipients after  Kidney Transplantation from HTLV-1 Positive Donors.
52nd ERA-EDTA Congress, 28-31 May 2015, London, United Kingdom.

Ishihara M, Araya N, Sato T, Fujii R, Tatsuguchi A, Saichi N, Nakagawa H, Yamano Y, Ueda K. Quantitative membrane proteome profiling to discover therapeutic targets for adult T-cell leukemia (ATL). AACR Annual Meeting 2014, 5-9 April, 2014, San Diego, USA.

Ishihara M, Araya N, Sato T, Fujii R, Tatsuguchi A, Saichi N, Nakagawa H, Yamano Y, Ueda K.
Label free quantitative proteome analysis on cerebrospinal fluid to discover severity grade markers for Human T-cell leukemia virus type 1 associated myelopathy/tropic spastic paraparesis (HAM/TSP).
HUPO 2013 12th Annual World Congress, 17 Sep(Tue) , 2013, Yokohama, Pacifico Yocohama, Kanagawa, Japan.

Yamano Y., Sato T., Coler-Reilly A., Ando H., Araya N., Yagishita N., Yamauchi J., Utsunomiya A., Jacobson S., Izumo S.
CXCL10, CXCL9 and Neopterin in cerebrospinal fluid as Candidate Prognostic Biomarkers for HAM/TSP.
The 16th International Conference on Human Retrovirology: HTLV and Related Viruses, 26-30 June, 2013,  Montreal, Canada.

Coler-Reilly A., Hashimoto M., Yagishita N., Sato T., Ando H., Yamauchi J., Araya N., Kimura M., Yamano Y., Takata A.
Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system.
The 16th International Conference on Human Retrovirology: HTLV and Related Viruses, 26-30 June, 2013,  Montreal, Canada.

Sato T., Ando H., Tomaru U., Yoshida M., Utsunomiya A., Yamauchi J., Araya N., Yagishita N., Coler-Reilly A., Jacobson S., Yamano Y.
Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP.
The 16th International Conference on Human Retrovirology: HTLV and Related Viruses, 26-30 June, 2013,  Montreal, Canada.

Yamano Y, Sato T, Ando H, Araya N, Yagishita N, Yamauchi J, Coler-Reilly A, Utsunomiya A, Jacobson S, Izumo S.
CXCL10 and Neopterin in cerebrospinal fluid are Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
The 16th International Conference on Human Retrovirology: HTLV and Related Viruses, June 2013, Montreal, Canada.

Sato T, Ando H, Tomaru U, Yoshida M, Utsunomiya A, Yamauchi J, Araya N, Yagishita N, Coler-Reilly A, Jacobson S, Yamano Y.
Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP.
The 16th International Conference on Human Retrovirology: HTLV and Related Viruses, June 2013, Montreal, Canada.

Coler-Reilly A, Hashimoto M, Yagishita N, Sato T, Ando H, Yamauchi J, Araya N, Kimura M, Yamano Y, Takata A.
Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system.
The 16th International Conference on Human Retrovirology: HTLV and Related Viruses, June 2013,  Montreal, Canada.

Yamano Y, Sato T, Coler-Reilly A, Ando H, Araya N, Yagishita N, Yamauchi J, Utsunomiya A, Jacobson S, Izumo S.
CXCL10, CXCL9 and Neopterin in cerebrospinal fluid as Candidate Prognostic Biomarkers for HAM/TSP.
The 16th International Conference on Human Retrovirology: HTLV and Related Viruses, June 2013,  Montreal, Canada.

Ishihara M, Araya N, Sato T, Fujii R, Tatsuguchi A, Saichi N, Nakagawa H, Yamano Y, Ueda K.
Label free quantitative proteome analysis on cerebrospinal fluid to discover severity grade markers for Human T-cell leukemia virus type 1 associated myelopathy/tropic spastic paraparesis (HAM/TSP).
HUPO 2013 12th Annual World Congress, 17 Sep, 2013, Yokohama, Japan.

Hasegawa A., Tamai Y., Takamori A., Sasada A., Tanosaki R., Choi I., Utsunomiya A., Maeda Y., Yamano Y., Eto T., Koh K., Nakamae H., Suehiro Y., Kato K., Takemoto S., Okamura J., Uike N., Kannagi M.
Identification of a novel HLA-DR1-restricted dominant epitope recognized by HTLV-1 Tax-specific CD4+ T-cells augmenting HTLV-1-specific CTL expansion in ATL patients after allogeneic HSCT.
AACR/JCA Joint Conference: Breakthroughs in Basic and Translational Cancer Research, 21-25 February, 2013, Maui, HI, U.S.A.

Yamano Y., Yudo K., Oka H., Shimizu J., Suzuki N.
Epidemiologic study of Relapsing polychondritis in Japan: Results of 239 cases.
International Conference on Orphan Drugs and Rare Diseases(ICORD) 2012 Conference, February 2012, Tokyo.

Yagishita N, Hasegawa D, Aratani S, Yamano Y, Nakajima T.
Importance of E3 ubiquitin ligase Synoviolin in fibrogenesis.
The 2011 ACR/ARHP Annual Scientific Meeting. November 2011, Chicago, U.S.A.

Yamano Y.
Human retrovirus promotes the plasticity of regulatory T cells into T helper type 1-like cells through the T-bet transcriptional activation in neuroinflammatory disease.
Bio-Rheumatology International Congress (BRIC) Tokyo:The 8th GARN Meeting November 2011, Tokyo.

Sato T, Fujii R, Konomi K, Yagishita N, Aratani S, Araya N, Aono H,  Yudoh K, Suzuki N, Beppu M, Yamano Y, Nishioka K, Nakajima T.
SPACIA1/SAAL1: A newly identified gene associated with aberrant proliferation of synovial fibroblasts.
Bio-Rheumatology International Congress (BRIC) Tokyo:The 8th GARN Meeting November 2011, Tokyo.

Yamano Y.
The contribution of Asian researchers to the field of rheumatology.
Tokyo-Shanghai Workshop on Rheumatology 2011. November 2011, Tokyo.

Yagishita N, Aratani S, Yamano Y, Nishioka K, Nakajima T.
ER stress signaling as a chronic inflammation.
2nd Tokyo-Shanghai Workshop on Rheumatology 2011, November 2011, Tokyo, Japan.

Ishihara M., Araya N., Sato T., Utsunomiya A., Yamano Y., Nakamura Y., Nakagawa H., Ueda, K.
Quantitative proteome profiling of CD4+CD25+CCR4+ T-cells to identify potential therapeutic targets for Human T-lymphotropic virus type-1 associated myelopathy (HAM) and adult T-cell leukemia.
HUPO 2011, 10th World Congress, Sep 2011, Geneva, Swiss.

Yamano Y, Sato T, Araya N, Yagishita N, Shimizu Y, Ando H, Utsunomiya A, Izumo S, Jacobson S, Suzuki N.
Clinical subtype of HAM/TSP based on clinical course and laboratory findings.
15th International Conference on Human Retrovirology: HTLV and Related Viruses, June 2011, Leuven, Belgium.

Sato T, Muto M, Araya N, Maekawa R, Suzuki N, Utsunomiya A, Seino K, Yamano Y.
Possibility of γδT cell immunotherapy for HTLV-1-infected individuals.
15th International conference on human retrovirology: HTLV and related Viruses, June 2011, Leuven, Belgium.

Araya N, Sato T, Utsunomiya A, Ando H, Yagishita N, Kannagi M, Nakamura T, Tanaka Y, Jacobson S, Yamano Y.
The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP.
15th International Conference on Human Retrovirology: HTLV and Related Viruses, June 2011, Leuven, Belgium.

Ueda K., Ishihara M., Ohsawa A., Senkoji N., Araya N., Sato T., Utsunomiya A., Yamano Y., Nakamura Y., Nakagawa, H.
Proteomic profiling of HTLV-1 infected T-cells for the Identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia.
15th International Conference on Human Retrovirology: HTLV and Related Viruses, June, 2011, Leuven, Belgium.

2010年以前の国際学会 はこちら 過去の国際学会.pdf